| scholarly article | Q13442814 |
| P2093 | author name string | Nora E Sarvetnick | |
| Kristina M Lorenzo-Arteaga | |||
| Robert Z Harms | |||
| Katie R Ostlund | |||
| Austin J Creer | |||
| Austin J. Creer | |||
| Katie R. Ostlund | |||
| Kristina M. Lorenzo-Arteaga | |||
| Nora E. Sarvetnick | |||
| Robert Z. Harms | |||
| P2860 | cites work | IL-18 Serum Level in Adult Onset Still's Disease: A Marker of Disease Activity | Q21296720 |
| Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling | Q22004163 | ||
| Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response | Q22008772 | ||
| Purification and characterization of the human interleukin-18 receptor | Q24316885 | ||
| A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity | Q24536244 | ||
| The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta | Q24544009 | ||
| Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18 | Q24671672 | ||
| Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action | Q26750452 | ||
| TNF biology, pathogenic mechanisms and emerging therapeutic strategies | Q26776492 | ||
| Converging roles of caspases in inflammasome activation, cell death and innate immunity | Q26776532 | ||
| Inflammasomes: mechanism of action, role in disease, and therapeutics | Q27001186 | ||
| Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis | Q27321681 | ||
| Cloning and expression of interleukin-18 binding protein | Q28139907 | ||
| IL-18 receptor beta-induced changes in the presentation of IL-18 binding sites affect ligand binding and signal transduction | Q28205474 | ||
| IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction | Q28258076 | ||
| IL-37 is a fundamental inhibitor of innate immunity | Q28295265 | ||
| Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor | Q28507342 | ||
| Functions of natural killer cells | Q29614300 | ||
| Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function | Q29617462 | ||
| K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter | Q29620146 | ||
| Functional reconstitution and regulation of IL-18 activity by the IL-18R beta chain | Q31837208 | ||
| Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer | Q73933704 | ||
| Interleukin-18 stimulates hematopoietic cytokine and growth factor formation and augments circulating granulocytes in mice | Q74541757 | ||
| IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice | Q77137045 | ||
| Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL-18 | Q78647029 | ||
| Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein | Q78946310 | ||
| CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity | Q82310845 | ||
| Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance | Q83864443 | ||
| High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein | Q84449474 | ||
| Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46 | Q33278681 | ||
| Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer | Q33372032 | ||
| Differences in signaling pathways by IL-1beta and IL-18. | Q34515880 | ||
| Endotoxin-induced serum factor that stimulates gamma interferon production | Q35091068 | ||
| Normal free interleukin-18 (IL-18) plasma levels in dengue virus infection and the need to measure both total IL-18 and IL-18 binding protein levels | Q35602926 | ||
| NK cell and DC interactions | Q35617660 | ||
| Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency | Q35865066 | ||
| A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus | Q35941368 | ||
| Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia | Q36281530 | ||
| Interleukin-18 binding protein transgenic mice are protected against ischemic acute kidney injury | Q36977361 | ||
| The trafficking of natural killer cells | Q36990612 | ||
| Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells | Q37179132 | ||
| Interleukin-18 and IL-18 binding protein | Q37220336 | ||
| Regulation of mouse NK cell development and function by cytokines | Q38174605 | ||
| Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression | Q38321870 | ||
| IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. | Q38328380 | ||
| Ly49 receptors: evolution, genetic diversity, and impact on immunity | Q38568870 | ||
| The many faces of Mac-1 in autoimmune disease | Q38673428 | ||
| Potential role of interleukin-18 in the immunopathogenesis of AIDS: involvement in fratricidal killing of NK cells | Q39865381 | ||
| IL-18 acts synergistically with IL-15 in stimulating natural killer cell proliferation | Q40217842 | ||
| A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancer | Q40417751 | ||
| Regulation of human IL-18 gene expression: interaction of PU.1 with GC-box binding protein is involved in human IL-18 expression in myeloid cells | Q40584237 | ||
| Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro | Q40733962 | ||
| IRAK and TAK1 are required for IL-18-mediated signaling | Q40763167 | ||
| Consequences of the crosstalk between monocytes/macrophages and natural killer cells | Q42567517 | ||
| A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases | Q43584281 | ||
| Defective NK cell activity and Th1 response in IL-18-deficient mice | Q43595287 | ||
| Identification of committed NK cell progenitors in adult murine bone marrow | Q43658855 | ||
| A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. | Q43702638 | ||
| Increased serum levels of soluble IL-18 receptor complex in patients with allergic asthma | Q44344454 | ||
| Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin | Q44559471 | ||
| Frontline: interferon regulatory factor-1 as a protective gene in intestinal inflammation: role of TCR gamma delta T cells and interleukin-18-binding protein | Q45015579 | ||
| IL-18 levels and the outcome of innate immune response to lipopolysaccharide: importance of a positive feedback loop with caspase-1 in IL-18 expression | Q45208945 | ||
| NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation | Q45304748 | ||
| Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. | Q45749099 | ||
| IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse | Q48550682 | ||
| Maturation of mouse NK cells is a 4-stage developmental program. | Q50602171 | ||
| In vivo developmental stages in murine natural killer cell maturation. | Q52120129 | ||
| Transferrin‘ activation: Bonding with transferrin receptors tunes KLRG1 function | Q57257146 | ||
| NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1 | Q57374973 | ||
| Combined Stimulation with Interleukin-18 and CpG Induces Murine Natural Killer Dendritic Cells to Produce IFN-γ and Inhibit Tumor Growth | Q58034330 | ||
| The natural soluble form of IL-18 receptor beta exacerbates collagen-induced arthritis via modulation of T-cell immune responses | Q64375431 | ||
| ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood | Q73086270 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | protein deficiency | Q18966920 |
| P304 | page(s) | 1020 | |
| P577 | publication date | 2017-08-28 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Interleukin (IL)-18 Binding Protein Deficiency Disrupts Natural Killer Cell Maturation and Diminishes Circulating IL-18. | |
| P478 | volume | 8 |
| Q52709434 | A new checkpoint for Natural Killer cell activation. |
| Q58580465 | Abnormal T Cell Frequencies, Including Cytomegalovirus-Associated Expansions, Distinguish Seroconverted Subjects at Risk for Type 1 Diabetes |
| Q90476077 | CD83+ CCR7+ NK cells induced by interleukin 18 by dendritic cells promote experimental autoimmune uveitis |
| Q57112108 | Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges |
| Q64275741 | Interleukin-18 in Health and Disease |
| Q90841067 | Remifentanil upregulates hepatic IL-18 binding protein (IL-18BP) expression through transcriptional control |
| Q47285858 | The family of the interleukin-1 receptors |
Search more.